Contamination of therapeutic human immunoglobulin preparations with apolipoprotein H (β2-glycoprotein I). - Wikidata - wikimedia - TriplyDB

Contamination of therapeutic human immunoglobulin preparations with apolipoprotein H (β2-glycoprotein I).

Contamination of therapeutic human immunoglobulin preparations with apolipoprotein H (β2-glycoprotein I).

http://www.wikidata.org/entity/Q35019430

about

Passive blood anaphylaxis: subcutaneous immunoglobulins are a cause of ongoing passive anaphylactic reaction.High-resolution physicochemical characterization of different intravenous immunoglobulin products.

P2860

Q41036946-CBEB4AE5-8912-4197-8A83-E20183D57015 Q41185651-5D0DD953-88E9-405D-84F5-2C4A4D2509EA

P2860

Contamination of therapeutic human immunoglobulin preparations with apolipoprotein H (β2-glycoprotein I).

http://www.wikidata.org/entity/Q35019430

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Contamination of therapeutic h ...... protein H (β2-glycoprotein I).

@ast

Contamination of therapeutic h ...... protein H (β2-glycoprotein I).

@en

type

label

Contamination of therapeutic h ...... protein H (β2-glycoprotein I).

@ast

Contamination of therapeutic h ...... protein H (β2-glycoprotein I).

@en

prefLabel

Contamination of therapeutic h ...... protein H (β2-glycoprotein I).

@ast

Contamination of therapeutic h ...... protein H (β2-glycoprotein I).

@en

P1433

Q35019430-991886A3-8FAC-480C-93F4-150A3635D837

P1476

Q35019430-80D08ED2-2759-4DAB-9403-23020F90B720

P2093

Q35019430-1787FCE3-A05F-493F-A001-9C647E7A6781

Q35019430-2DF889EC-5928-422A-8F5C-F12C1A4ED937

Q35019430-456D3089-96E8-47BF-A198-2E00C300B6FA

Q35019430-8EB65E19-30E7-45B4-B799-86305338A115

Q35019430-9FA7FD0B-F265-4599-8E2F-7D9F6E001492

Q35019430-AEE38B95-F027-4FE3-A4CF-097DC78DB938

Q35019430-B624B16E-46FD-498A-B9C4-CB72FB9C7A10

Q35019430-BAF36513-BF12-4C6F-87C0-C14FFAB577C6

Q35019430-FF907494-2FF0-4115-A8CB-4F8014D65F05

P2860

Q35019430-05A0DFE6-79F9-47C0-9DD6-691B9306F2D0

Q35019430-16929646-2B83-4104-AB65-259A297C0C16

Q35019430-21D1F4DA-F569-4A13-A525-679644ED730F

Q35019430-27E367C7-995A-45E1-911B-AD474CC65ACC

Q35019430-295A7CDE-AE5A-429E-8294-CF40BC2CADF2

Q35019430-662FE345-DFBE-40DC-880F-D549AD9D3C8E

Q35019430-A960BD4A-CFF8-4B9D-ABEA-4C56CB2970C2

Q35019430-BD8D3FFA-801F-41CA-A7AD-7A36549EC2EB

Q35019430-CF4A9535-5C5D-409E-8CC5-4F8C3CEA0177

Q35019430-D25DDD2C-37EF-4B00-A394-E71340229ED0

P304

Q35019430-FA90B8D7-05E5-4DE5-AE71-AEEA47966955

P31

Q35019430-4D88B3C5-1B6A-48FC-AF55-D64B6406E257

P356

Q35019430-DE60E1C5-D6F9-4E93-8F90-09DFC085B78E

P433

Q35019430-C64B6489-4B1A-4436-97B1-456A9C8620E7

P478

Q35019430-83A1769B-C0A3-4060-9FEC-D13B32377557

P577

Q35019430-16250BE1-B834-40C8-914A-E0CDA313214A

P698

Q35019430-35BDE1CE-59F4-439E-B813-828DC0408B34

P356

P1433

Electrophoresis

P1476

Contamination of therapeutic h ...... protein H (β2-glycoprotein I).

@en

P2093

Alexandra Seifner

http://www.w3.org/2001/XMLSchema#string

Dieter Pullirsch

http://www.w3.org/2001/XMLSchema#string

Ebrahim Razzazi-Fazeli

http://www.w3.org/2001/XMLSchema#string

Friedrich Lackner

http://www.w3.org/2001/XMLSchema#string

Gerhard Beck

http://www.w3.org/2001/XMLSchema#string

Ingrid Miller

http://www.w3.org/2001/XMLSchema#string

Karin Hummel

http://www.w3.org/2001/XMLSchema#string

Manfred Gemeiner

http://www.w3.org/2001/XMLSchema#string

Stephanie Eichmeir

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

Crystal structure of human β2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

Redox options in two-dimensional electrophoresis.

Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological Societies.

Mass spectrometric analysis of intact human monoclonal antibody aggregates fractionated by size-exclusion chromatography.

Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I.

Other than IPG-DALT: 2-DE variants.

β(2) -Glycoprotein I: evolution, structure and function.

Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen.

P304

515-521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ELPS.201300319

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24132587

http://www.w3.org/2001/XMLSchema#string